Skip to main content
. 2020 May 13;20(1):517–524. doi: 10.3892/ol.2020.11605

Figure 3.

Figure 3.

Differences in TIDE prediction score between the two CRC subtypes in (A) The Cancer Genome Atlas and (B-D) three validation CRC cohorts. CRC, colorectal cancer; TIDE, tumor immune dysfunction and exclusion.